OpenAI could reportedly delay IPO if it takes a fresh funding round
Private companies weighing a new primary round against a listing have, in past episodes of this kind, tended to accept the private capital when it arrives on better terms than public markets are offering, with the IPO timetable slipping as a consequence rather than as a signal of distress.
PBoC injects CNY 110bln via 7-day reverse repos with the rate at 1.40% and CNY 600bln in overnight reverse repos
PBoC sets USD/CNY mid-point at 6.7628 vs Exp. 6.7148 (prev. 6.7670)
OpenAI could reportedly delay IPO if it takes a fresh funding round
Australia sells AUD 1bln in 3.75% April 2037 bonds, b/c 3.85, avg. yield 5.3910%
Nippon Steel (5401 JT) plans to invest around EUR 900mln in Kosice Steelworks
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
The distinction worth drawing is between a delay driven by valuation tension, where insiders prefer not to print a down-round public debut, and one driven by simple funding needs being met privately, since only the former says anything about where the eventual listing prices. For the listed names in the orbit, the transmission runs through the large strategic shareholder on the tape rather than through any direct read-across to sector earnings; private funding events have historically been digested as a sentiment datapoint on the AI capex theme, not a cash flow event. The sourcing is reported rather than confirmed, which in comparable situations has meant the detail moves before the fact. Worth watching are the size, pricing and participant list of any round that does materialise, and whether the strategic backer participates, since that has tended to be the cleaner signal on the relationship than the listing calendar itself.
Related headlines
- OpenAI weighs a funding round at a USD 1.2tln valuation before IPO, according to FT4 hours ago
- OpenAI says that it is collaborating with Anthropic and Google (GOOGL) on AI safety12 hours ago
- OpenAI backs bipartisan push to address Ai biothreats, reports Politico6 hours ago
- Oracle (ORCL) to invest in over 1.7 GW of carbon-free wind projects in Texas; electricity to be supplied by Engie (ENGI FP), RWE (RWE GY) and Clearway13 hours ago
- NVIDIA (NVDA) CEO Jensen Huang to attend US state dinner for Chinese President Xi5 hours ago
- Google (GOOGL) launches Gemini 3.8 live dialogue models9 hours ago
- Meta (META) will reportedly roll out next-gen Astrid chips at the end of 2027; to deploy new in house Arke chips in H1 202712 hours ago
- Micron (MU) says it expects 512GB RDIMM to enter mass production in H2 202713 hours ago
- US BROKER MOVES: ULTA upgraded at Wells Fargo; APTV downgraded at JPM14 hours ago
- Crusoe has signed a multi-year deal with Perplexity AI, offering Nvidia (NVDA) chips to Perplexity in a cloud deal, Bloomberg reports14 hours ago
- Salesforce (CRM) and Google Cloud (GOOGL) expand their enterprise AI partnership14 hours ago
- Salesforce (CRM) says it will integrate NVIDIA (NVDA) NeMoTron-based models and accelerated computing into Missionforce, with fine-tuned NVIDIA models available to select customers in October 202614 hours ago
- Citi (C) reports August net charge offs of 2.03% (prev. 1.90%) and delinquency rate 1.29% (prev. 1.27%)8 hours ago
- Boeing (BA) close to finalising order for 150 Max jets to Turkish airlines after engine maintenance dispute resolved, according to reports10 hours ago
- Morgan Stanley (MS) exec says they are in relatively early to middle innings of AI financing11 hours ago
- Dollar General (DG) says consumers across all income cohorts are increasingly distressed by ongoing inflation; middle- and upper-middle income consumers are showing behaviours similar to lower-income customers11 hours ago
- Truist Financial (TFC) notes that management said the business was "kind of break even" in H1, despite really good credit quality12 hours ago
- Home Depot (HD) plans to keep current everyday-low-price positioning through H2'26, despite potential P&L pressure; adds that the Co. has been less promotional; maintains FY26 guidance12 hours ago
- Abbvie (ABBV) says that Apogee's global Phase 3 atopic dermatitis program is seen to begin enrollment in 2026, targeting an early-2030 launch12 hours ago
- US EQUITY OPEN: Stocks open with slight downward bias but energy stocks soar on firmer crude prices12 hours ago
The whole workspace, free to try.
Try it free